PCV77 COST EFFECTIVENESS ANALYSIS THE PREVENTION OF VENOUS THROMBOEMBOLISM IN IMMOBILIZED PATIENTS (PREVENT) TRIAL- THROMBOPROPHYLACTIC TREATMENT WITH DALTEPARIN VERSUS PLACEBO IN ACUTELY ILL PATIENTS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72796-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72796-0/fulltext
Title :
PCV77 COST EFFECTIVENESS ANALYSIS THE PREVENTION OF VENOUS THROMBOEMBOLISM IN IMMOBILIZED PATIENTS (PREVENT) TRIAL- THROMBOPROPHYLACTIC TREATMENT WITH DALTEPARIN VERSUS PLACEBO IN ACUTELY ILL PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72796-0&doi=10.1016/S1098-3015(10)72796-0
First page :
Section Title :
Open access? :
No
Section Order :
361